Thursday, 30 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > Higher dose of Wegovy ups both weight loss and side effects
Tech and Science

Higher dose of Wegovy ups both weight loss and side effects

Last updated: September 25, 2025 11:52 am
Share
Higher dose of Wegovy ups both weight loss and side effects
SHARE

Weekly Wegovy injections can enhance weight loss for individuals

James Manning/PA Images/Alamy

Recent clinical trials reveal that increasing the dosage of Wegovy can lead to more significant weight loss, albeit with a higher chance of side effects. Wegovy, which contains the active ingredient semaglutide, has previously demonstrated efficacy in helping individuals lose approximately 15% of their body weight within a year, provided it’s combined with an appropriate diet and exercise. The drug mimics glucagon-like peptide-1 (GLP-1), a hormone that induces appetite suppression and slow digestion.

Produced by Novo Nordisk, Wegovy is prescribed for those struggling with obesity and individuals who carry excess weight accompanied by health issues like type 2 diabetes. “Some patients either do not respond optimally or want to achieve greater than the typical 10 to 15 percent body weight loss,” states Lora Heisler, a researcher who was not involved in the study.

To investigate whether increasing the dosage could enhance results, Sean Wharton from the University of Toronto alongside colleagues from Novo Nordisk enlisted over 1,000 adults battling obesity across 11 countries, including the United States, Canada, and various European nations.

Participants were randomly assigned to receive either a standard weekly injection of semaglutide at 2.4 mg, an elevated dosage of 7.2 mg, or a placebo. The semaglutide dosage was progressively increased over several weeks before reaching the assigned level, while all participants were encouraged to maintain a calorie deficit of 500 calories daily and engage in 150 minutes of weekly exercise.

After a year of treatment, the standard dosage group reported an average weight loss of 16%, while those on the higher dosage achieved approximately 19%. The placebo group, in contrast, lost an average of only 4% of their weight. Notably, around one-third of patients receiving the standard dose saw weight reductions exceeding 20%, compared to nearly half of the participants in the higher dose group. Only 3% of the placebo group matched this outcome, indicating the superior efficacy of the higher dosage.

See also  Sugar consumed through soda, fruit juice consistently linked to higher risk of developing type 2 diabetes

Initially, more than a third of all participants exhibited prediabetes; however, by the conclusion of the trial, the high-dose group saw an 83% reduction in prediabetes cases, versus a 74% decrease in the standard dosage group. “This is encouraging, as the primary goal of the weight loss is to enhance health,” remarks Heisler.

Nevertheless, the study highlights potential adverse effects. Among those receiving the standard dose, 61% encountered gastrointestinal symptoms such as nausea and diarrhea—this figure rose to 71% for participants on the higher dosage, whereas only 40% of those in the placebo group reported similar issues. These symptoms can sometimes stem from factors unrelated to medication, indicates Heisler.

Moreover, over 20% of the high-dose group experienced dysesthesia, a distressing skin sensation that led four participants to discontinue the treatment, while only 6% of those receiving the standard dose and one participant on the placebo reported this side effect without ceasing treatment.

Overall, the findings suggest that the advantages of a higher Wegovy dose could outweigh potential risks for certain individuals, according to Heisler. “For those requiring more significant weight loss without severe side effects, increasing the dosage may be beneficial,” she shares. However, she emphasizes that this might not be appropriate for individuals achieving satisfactory weight loss with the standard dose or experiencing heightened side effects. Further studies need to corroborate these results prior to clinical implementation.

Additionally, Wharton and his colleagues discovered preliminary evidence indicating that a higher dose could also facilitate greater weight loss and improvements in blood sugar levels for individuals with concurrent obesity and type 2 diabetes. However, results remained statistically insignificant, necessitating additional research as stated by Simon Cork from Anglia Ruskin University, UK.

See also  Google strikes world's largest biochar carbon removal deal with Indian startup Varaha

Topics:

This rewritten content maintains the original HTML structure, incorporates the key points from the provided article while ensuring it is unique, and is ready for integration into a WordPress platform.

TAGGED:doseeffectshigherLosssideUpsWegovyWeight
Share This Article
Twitter Email Copy Link Print
Previous Article Fatal shooting of 13-year-old NYC boy likely over gang beef, cops say — while IDing teen suspect Fatal shooting of 13-year-old NYC boy likely over gang beef, cops say — while IDing teen suspect
Next Article Hillary Clinton Sparks Outrage as She Appears to Suggest 'Christian White Men' Are 'Causing Damage' to America During 'Morning Joe' Appearance — Just Two Weeks After Charlie Kirk's Assassination Hillary Clinton Sparks Outrage as She Appears to Suggest 'Christian White Men' Are 'Causing Damage' to America During 'Morning Joe' Appearance — Just Two Weeks After Charlie Kirk's Assassination
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Nikki Glaser Loved Taylor Swift’s 2024 VMAs Shout-Out to Travis Kelce

Nikki Glaser, the well-known comedian, is not only a fan of Taylor Swift's music but…

September 15, 2024

With Rubiales gone (and guilty of sexual assault), is Spanish football rethinking how it treats women?

Last Friday night, the Spain women's team showcased a remarkable comeback against Belgium in their…

February 26, 2025

EXCLUSIVE: 'Frustrated' Prince William Left 'Disgusted' by Harry's Attempt to 'Manipulate' Cancer-Stricken Dad Charles During Reunion… as Future King Refuses to Welcome Back Brother

Exclusive Insight Source: MEGAPrince William remains skeptical about his brother, Harry's motives for rejoining the…

September 26, 2025

Etro Resort 2026 Collection | Vogue

Exploring the Maximalist World of Etro with Marco De VincenzoMarco De Vincenzo has always been…

June 5, 2025

Scientists Discover a Simple Method to Reduce Mercury Levels in Tuna : ScienceAlert

The Benefits of Reducing Mercury Levels in Fish Through Innovative Packaging Consuming fish as part…

April 6, 2025

You Might Also Like

Chimpanzee Metacognition Allows Humanlike Belief Revision
Tech and Science

Chimpanzee Metacognition Allows Humanlike Belief Revision

October 30, 2025
MCP stacks have a 92% exploit probability: How 10 plugins became enterprise security's biggest blind spot
Tech and Science

MCP stacks have a 92% exploit probability: How 10 plugins became enterprise security's biggest blind spot

October 30, 2025
Sorry, but interstellar visitor 3I/ATLAS really is a comet, not aliens
Tech and Science

Sorry, but interstellar visitor 3I/ATLAS really is a comet, not aliens

October 30, 2025
Sorry, but interstellar visitor 3I/ATLAS really is a comet, not aliens
Tech and Science

Sorry, but interstellar visitor 3I/ATLAS really is a comet, not aliens

October 30, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?